Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today ...

As part of the NORHED II project Partnership for Peace: Better Higher Education for Resilient Societies, PRIO hosted a ...

“We know from data that primary care, which sees over 90% of patients with type 2 diabetes, that there’s not much uptake or ...

New research finds that a certain workout plan may make you less impulsive. Experts explain how it works and what the ...

New research in Medicine & Science in Sports & Exercise suggests exercise may be one way to boost that self-control. Specifically, researchers found that an aerobic activity protocol improved ...

Acute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in ...

If not remedied, the current shortage of academically qualified accounting faculty stands to affect student learning and the fulfillment of universities' ...

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...

Every 27 minutes, someone in Australia is diagnosed with Parkinson's disease. Best known for its tremors, movement and ...

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and ...

Michael Saylor’s Strategy has filed to offer STRE, euro-denominated shares that it will use to fund more Bitcoin buys.

The program's core curriculum builds upon the Wharton School's prior research on emerging AI technology to help participants ...